Press & Media

Madison Meds is a family-owned, Florida-based telehealth platform that connects eligible patients with an independent network of US-licensed providers and US-licensed compounding pharmacies. The company was founded to fill the service-level gaps in modern telehealth, offering fair pricing and concierge-level service across compounded GLP-1, peptides, hair and skin, and longevity-focused care. We work with reporters, editors, and producers covering this category — from market and pricing trends to patient access and the difference between a US-licensed compounding pharmacy and the grey market.

For media inquiries, deadline-driven requests, or to request anonymized clinical commentary routed through our provider network coordinator, please use the contact form below or email ask@madisonmeds.com with “PRESS” in the subject line.

Founder & Spokesperson

Michael N. Zachman

Founder & Owner, Madison Meds

Madison Meds is a family-owned company founded to fill the service-level gaps left by the current crop of telehealth competitors. The mission is simple: fair pricing, concierge-level service, and honest education that helps people improve their lives through groundbreaking therapies prescribed by licensed physicians and tailored to each patient’s needs — without forcing anyone into the grey market to get them.

Michael speaks to the operational, market, and patient-experience side of telehealth, including how independent providers, US-licensed compounding pharmacies, and direct-to-consumer brands fit together in 2026 — and why a family-run model is built differently from venture-backed competitors.

Available for: on-the-record commentary on operations, patient demand patterns, pricing trends, regulatory access, and consumer education. Clinical and prescriber questions are routed through our independent provider network coordinator and answered on background or attributed to “a licensed provider in the Madison Meds network.”

Best ways to reach: ask@madisonmeds.com · 561-919-9722 (text)

Company Fact Sheet

Categories covered on the platform

• GLP-1 weight management: compounded semaglutide and tirzepatide, including microdose protocols, available after a licensed-provider evaluation through a US-licensed compounding pharmacy.
• Wellness peptides: BPC-157, CJC-1295, Sermorelin, GHK-Cu, Glutathione, NAD+, and combination stacks studied in research for tissue support, sleep architecture, and recovery.
• Recovery stacks: the Madison Meds Wolverine blend (BPC-157 + TB-500) is a provider-guided peptide stack studied in research for tissue support and recovery, available to eligible patients after a licensed-provider evaluation through a US-licensed compounding pharmacy.
• Skin radiance: the Madison Meds Glow blend (GHK-Cu + BPC-157 + TB-500) is a provider-guided peptide stack focused on skin quality, hydration, and collagen support, available to eligible patients after a licensed-provider evaluation.
• Hair and skin: physician-guided regimens including topical and injectable options for hair density and skin quality.
• Energy and longevity: NAD+ protocols and supportive wellness peptides may be considered for eligible patients during evaluation.

Available Expert Topics

The founder is available to comment on operational, market, and access angles. For clinical and dosing questions, we coordinate background or attributed responses with a licensed provider in the Madison Meds network.

Press Kit & Brand Assets

Logos, brand colors, and product imagery for editorial use. Please credit “Courtesy of Madison Meds” and link to madisonmeds.com when possible.

Boilerplate

About Madison Meds: Madison Meds is a family-owned, Boca Raton, Florida-based telehealth platform that connects eligible patients with an independent network of US-licensed providers and US-licensed compounding pharmacies. The company was founded to fill the service-level gaps left by larger telehealth competitors, offering fair pricing and concierge-level service across compounded GLP-1 medications, peptide therapies, hair and skin wellness, and longevity-focused care. The model is built around licensed-provider evaluations and US-licensed compounding pharmacies so patients can access groundbreaking therapies tailored to their needs without resorting to the grey market. Eligibility, treatment, and any prescription are determined by an independent licensed provider during evaluation. Educational content on the site is for informational purposes only and is not medical advice. Outcomes are individual. Learn more at madisonmeds.com.

Journalist Contact Form

For interview requests, fact-checks, or press inquiries, please complete the form below. We aim to respond within one business day. Tight deadline? Note it in your message and email ask@madisonmeds.com with “PRESS” in the subject line.

Request a Clinical Source

Need attributed or background commentary from a licensed provider? Madison Meds works with an independent network of US-licensed providers. We can route your request to the network coordinator, who will offer comments on background or attributed to “a licensed provider in the Madison Meds network.”